Searched for
PHARMA INGREDIENTS MAKER
Bonus issue & stock split: Last day to buy shares of this smallcap company before record date. Do you own?Anlon Healthcare's shares will trade ex-record date tomorrow for its 1:1 bonus issue and 1:5 stock split, making today the last chance for ...- Sudeep Pharma IPO subscribed 93.71 as on final day: Check GMP, other detailsSudeep Pharma’s Rs 895-crore IPO enters its final bidding day with strong overall demand, led by robust NII and retail participation. Despi...
- Sudeep Pharma IPO: Mukul Agrawal, Prashant Jain among investors in Rs 268 crore anchor bookSudeep Pharma secured strong anchor investor participation ahead of its IPO, attracting major mutual funds, insurers and marquee investors,...
- Ingredion open for acquisitions, partnerships in India to expand businessThe $7 billion (CY2021) company by revenues entered India a decade ago, but after couple of years of prospecting it decided last year to ac...
- Glenmark Life Sciences Q3 Results: Profit rises 1% on API strengthGlenmark Life Sciences, which was spun off from Glenmark Pharmaceuticals in 2019 to focus on the API business, posted revenue from operatio...
- Optimus Pharma to launch COVID-19 drug Molnupiravir shortlyThe firm has developed the API (active pharmaceutical ingredient) in house at its R&D centre here. Optimus Pharma has revealed highly promi...
- Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in IndiaAs the threat of compulsory licence (CL) looms over big pharma in India, companies are rushing in to sign voluntary licensing agreements th...
- Natco Pharma gets registration approval from CIB&RC for Chlorantraniliprole"Natco Pharma is pleased to announce its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC)... for ...
- Indian drug companies seek cure for Donald Trump’s 'Buy-American' planThe presidential order issued on August 6 called for federal agencies involved in the procurement of essential medicines, medical counterme...
- Lupin, Piramal Healthcare in race for stake in JB ChemicalsPiramal said it does not comment on market speculation, Lupin did not respond to ET’s query.
- Dr Reddy's gets FDA nod for 'Tosymra' migraine nasal sprayThe drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.
- Orchid Pharma’s lenders reject Union Quimico’s bidThe resolution professional who is in charge of the management of the Chennai-based company has set April 25 as the fresh date for submitti...
- Orchid gets three final bids at par with liquidation valueThe company had to sell assets to rein in debt. In 2012, it sold its penicillin business to US drug maker Hospira for $200 million.
- IPO watch: Laurus issue opens today, good business model may make it a hitThe company is raising Rs 1,330 crore in the primary market. Proceeds of Rs 225 crore from the issue will be used to reduce debt on the com...
- Torrent Pharma buys Glochem Unit in VizagET had reported in its May 27 edition that the two companies are in advanced talks for a possible transaction.
- Pharma stocks slip on fears of US clamp downBulk drugs, or active pharmaceutical ingredients (APIs), are the ingredients used to give a drug its therapeutic effect.
- Sun Pharma gets boost with US FDA approval for GleevecSun Pharmaceutical announced it received approval from the US FDA for generic copies of Gleevec, a drug that treats chronic myeloid leukemi...
- Positive on API manufacturers, prefer Sequent Scientific: Prakash DiwanThe buying of warrants by the promoter group of Sequent Scientific reflects their confidence in the business, points out Diwan.
- Granules India agrees to acquire Auctus PharmaThe acquisition process is expected to be completed in the next 3 to 6 months, a release from Hyderabad-based Granules India said.
- Now, China turns the heat on India’s vaccine makersAfter spitting fire at Indian pharma sector's active pharma ingredients (APIs) makers, the Chinese dragon is now turning its wrath on India...
Load More
